Search alternatives:
patients decrease » point decrease (Expand Search), treatments decreased (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
i largest » _ largest (Expand Search)
i large » ai large (Expand Search), _ large (Expand Search), a large (Expand Search)
patients decrease » point decrease (Expand Search), treatments decreased (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
i largest » _ largest (Expand Search)
i large » ai large (Expand Search), _ large (Expand Search), a large (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Geographical distribution of large cities and small cities.
Published 2024“…The Figure reveals two patterns: 1) the maximum level of innovation is higher in large cities (2.53) than in small cities (2.02); 2) among large cities in <b>a</b>, innovation levels in general decrease with nightlight density. …”
-
9
-
10
Baseline patient characteristics across neutralizing monoclonal antibody trials.
Published 2025Subjects: -
11
-
12
-
13
Image 1_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif
Published 2025“…A follow-up process for 13 patients diagnosed with early-stage lung cancer revealed that 10 of the 15 decreased autoantibodies would recover to a higher level after the tumor was resected. …”
-
14
-
15
-
16
-
17
-
18
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
Published 2025Subjects: -
19
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
Published 2025Subjects: -
20
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
Published 2025Subjects: